| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Hydroxyapatite 830 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
|
| Hydroxyapatite 3.32 g oral granules sachet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
|
| Hydroxyapatite-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
|
| Product containing calcium hydroxyapatite and carboxymethylcellulose sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
|
| Product containing calcium hydroxyapatite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Calcium hydroxyapatite microsphere suspension in aqueous based carrier 0.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
|
| Calcium hydroxyapatite microsphere suspension in aqueous based carrier 1.3mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
|
| Calcium hydroxyapatite crystal |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Durapatite (substance) |
Inferred relationship |
Some |
|
| Hydroxyapatite only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Carmellose- and hydroxyapatite-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
2 |
| Carmellose and hydroxyapatite only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
2 |
| Carmellose- and hydroxyapatite-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
2 |
| Carmellose and hydroxyapatite only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
2 |
| Hydroxyapatite 830 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite 830 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite 3.32 g oral granules sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite 3.32 g oral granules sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
| Hydroxyapatite only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Durapatite (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]